Gilead's expansion beyond HIV therapies will surprise many investors.
Roivant Sciences builds small, focused subsidiaries called Vants that develop drug products and technologies to treat various ...
Zacks Investment Research on MSN
Gilead Sciences (GILD) stock dips while market gains: Key facts
In the latest close session, Gilead Sciences (GILD) was down 3.72% at $129.83. The stock's performance was behind the S&P 500's daily gain of 0.42%. Meanwhile, the Dow gained 0.29%, and the Nasdaq, a ...
Neutra Corp (OTC: NTRR), a company focused on health, wellness, and life sciences, today announced its forward-looking strategy for the third and fourth quarters of 2026, centered on deepening ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...
Applications are now open for the 'Bharat Life Sciences Award' (BLSA)--a first-of-its-kind national platform to recognise excellence across India's life sciences ecosystem. Backed by a total grant ...
Sai Life Sciences Limited (BSE: 544306 \| NSE: SAILIFE), one of India’s leading integrated contract research, development, and ma ...
The subject area represents the next stage of the database’s evolution, and heralds other proposed changes to journal selection and article categorization. The first Nature Index tables in the applied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results